Eltrombopag

Uses of Eltrombopag

Eltrombopag is commonly used to treat Chronic Idiopathic Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Chronic Hepatitis C Infection and aplastic anemia.

How Eltrombopag Works

Eltrombopag is a haemostatic which exerts its action on the pathway regulating megakaryopoiesis and platelet production. Eltrombopag will activate thrombopoietin (TPO) receptor agonist, initiating marrow progenitor cells proliferation and differentiation. Therefore, platelets will increase.

Side Effects of Eltrombopag

Upper respiratory tract infection, Cough, Fever, Anaemia, Decreased appetite, Paraesthesia, Dry eye, Vision blurred, Eye pain, Ear pain, Vertigo, Cough, Hot flush, Nausea, Diarrhea, Rash, Alopecia, Hyperhidrosis, Petechiae, Musculoskeletal pain

Information About Eltrombopag

Eltrombopag is a thrombopoietin receptor agonist used to treat chronic immune thrombocytopenia, aplastic anaemia, and thrombocytopenia in hepatitis C in Singapore. Available as a 12.5mg–75mg oral tablet taken once daily on an empty stomach, it is HSA-registered and available on prescription only in Singapore. It must be taken two hours before or four hours after dairy products, calcium-fortified foods, antacids, or mineral supplements as polyvalent cations form insoluble chelates with eltrombopag, significantly reducing its oral bioavailability. A valid doctor's consultation is required before dispensing. Order Eltrombopag online at DoctorOnCall Singapore with same-day delivery available. Speak to a DoctorOnCall physician today to check if Eltrombopag is right for you.


Eltrombopag is a medication commonly used to treat low platelet counts in conditions such as chronic immune thrombocytopenia and certain blood disorders. It works by stimulating the bone marrow to produce more platelets, helping reduce the risk of bleeding. Eltrombopag belongs to a class of medications known as thrombopoietin receptor agonists and is widely used in haematology care. Find affordable Eltrombopag options from trusted brands at DoctorOnCall.

Conclusion

Consult our doctors online for safe and effective use of Eltrombopag tailored to your health needs. Find the best prices for affordable Eltrombopag tablets and oral suspensions at DoctorOnCall Singapore.


Warnings

Kidney Use With Care

Eltrombopag should be used with caution and close monitoring of their renal function in patients with mild kidney disease. Dose adjustment of Eltrombopag may be needed. Please consult your doctor before using it. Use of Eltrombopag in patients with moderate to severe kidney disease has not been studied adequately.

Alcohol Not Advisable

Even though there is insufficient data on drug interactions between alcohol and Eltrombopag. However, generally drinking alcoholic beverages should be kept to a minimum or avoided completely. Please consult your doctor before using it.

Pregnancy Not Safe

Eltrombopag may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the fetus, however, there are limited human studies. The benefits from use in pregnant women may outweigh the risk. Please consult your doctor before using it.

Driving Generally Safe

Eltrombopag may cause side effects such as blurring of vision and vertigo all of which could affect your ability to concentrate and drive. Do not drive unless you are feeling well.

Liver Limited Data

Eltrombopag should be used with caution in patients with mild to moderate liver disease. Dose adjustment of Eltrombopag may be needed. Please consult your doctor before using it. Use of Eltrombopag in patients with severe liver disease is contraindicated.

Lactation Limited Data

Eltrombopag is excreted into the breastmilk of animal studies but its excretion into human breast milk is largely unknown. The decision whether to discontinue breast-feeding or to withhold from Eltrombopag therapy is to be after consulting with your doctor.

Frequently Asked Questions

Written by

Dr. Adeline Carol Peters

, Bachelor of Medicine and Bachelor of Surgery (MBBS) — Manipal Academy of Higher Education (MAHE)

Reviewed by

Dr. Mohd Izzat Amir Bin Awang

, Doctor of Medicine (MD), University of Mansoura - Manchester